10 results match your criteria: "Ludwig Boltzmann Institute for Urological Oncology[Affiliation]"
World J Urol
August 2006
Department of Urology and Andrology, Ludwig Boltzmann Institute for Urological Oncology, Donauspital - SMZO, Langobardenstrasse 122, 1220, Vienna, Austria.
The objective of this study was to assess lower urinary tract symptoms (LUTS), urinary incontinence (UI), erectile dysfunction (ED) and quality of life after radical prostatectomy (RPE) and external beam radiation therapy (EBRT) in a "real-life" setting. A consecutive series of patients undergoing routine follow-up after RPE and EBRT at 28 Austrian institutions were analyzed. Men who received adjuvant therapy were excluded.
View Article and Find Full Text PDFAging Male
May 2006
Department of Urology, Danube Hospital & Ludwig Boltzmann Institute for Urological Oncology, Vienna, Austria.
Objective: The aim of this study was to evaluate the association between serum levels of testosterone and free testosterone to lifestyle in aging males.
Methods: Men between 45 and 85 years were assessed regarding body mass index (BMI), nicotine and alcohol consumption, stress level, physical and social activity, and sleeping quality by a self-administered questionnaire. In parallel, serum levels of testosterone (T), free testosterone (fT), LH, FSH, DHEA-S, E2 and SHBG were obtained.
World J Urol
December 2005
Department of Urology and Andrology, Ludwig Boltzmann Institute for Urological Oncology, Danube Hospital, Langobardenstrasse 122, 1220, Vienna, Austria.
The aim of this study is to evaluate the proportion of repeat biopsies after 7 years in men with an initial benign six- or ten-core biopsy as well as the incidence of prostate cancer (PC) in the repeat biopsies. In this retrospective longitudinal study, 116 men with an elevated prostate-specific antigen (PSA) and/or a suspicious digital rectal examination (DRE) who have had a benign prostate biopsy between January 1997 and September 1997 were included. Fifty-eight men had an initial benign six-core biopsy (median PSA 7.
View Article and Find Full Text PDFBJU Int
April 2005
Department of Urology and Andrology, Ludwig Boltzmann Institute for Urological Oncology, Vienna, Austria.
Objective: To determine in a prospective study the effect on erectile function of (103)Pd brachytherapy for localized prostate cancer, using a validated questionnaire.
Patients And Methods: Between July 1999 and April 2003, 113 men with localized prostate cancer were treated by permanent implantation of (103)Pd seeds, of whom 78 with a follow-up of 30 months were included in this study. No patient received supplemental external beam radiation therapy.
Eur Urol
January 2005
Department of Urology and Andrology, Ludwig Boltzmann Institute for Urological Oncology, Donauspital, Langobardenstrasse 122, A-1220 Vienna, Austria.
Purpose: To assess prevalence and risk factors for erectile dysfunction (ED) by using the International Index of Erectile Function- 5 (IIEF-5) in men undergoing a health investigation.
Methods: Men aged 20-80 years participating in a health-screening project in the area of Vienna completed the IIEF-5 for evaluation of ED. In parallel, all men underwent a detailed health examination including physical assessment, evaluation of various life-style factors, medical history and a blood analysis.
BJU Int
October 2004
Department of Urology and Andrology, Ludwig Boltzmann Institute for Urological Oncology, Donauspital, Vienna, Austria.
Urology
July 2004
Department of Urology, Ludwig Boltzmann Institute for Urological Oncology, Donauspital, Vienna, Austria.
Objectives: To present our experience with elective, open, nephron-sparing surgery for renal masses in a contemporary, consecutive series.
Methods: In this retrospective study, the files of all patients who underwent elective nephron-sparing surgery between January 1996 and December 2002 at our institution were reviewed. The preoperative workup included renal ultrasonography and abdominal computed tomography.
Eur Urol
May 2004
Department of Urology and Ludwig Boltzmann Institute for Urological Oncology, Donauspital, Langobardenstrasse 122, A-1220 Vienna, Austria.
Wien Klin Wochenschr
December 2003
Department of Urology and Andrology, Ludwig Boltzmann Institute for Urological Oncology, Donauspital, Vienna, Austria.
Purpose: The aim of this study was to determine prevalence and risk factors for erectile dysfunction (ED) in men undergoing a health investigation.
Methods: Men aged 30-69 yrs participating in a health screening project in the area of Vienna completed a 11-item questionnaire on ED which was extracted from the international index of erectile function (IIEF). In parallel, all men underwent a detailed health examination including physical assessment, evaluation of various life-style factors and a blood analysis with 14 parameters.
Aging Male
December 2002
Department of Urology and Andrology and Ludwig Boltzmann Institute for Urological Oncology, Danube Hospital, Langobardenstrasse 122, 1220 Vienna, Austria.
Objectives: A number of interactions between age-related changes in serum levels of dehydroepiandrostendione sulfate (DHEA-S) and estradiol and symptoms of aging men have been proposed, yet data regarding this issue are scant. We therefore set up a prospective study to analyze these associations.
Methods: In a prospective, cross-sectional study, men aged 45-85 years were recruited.